Semaglutide is a prescription medicine that belongs to the GLP-1 receptor agonist class. It has become one of the most widely discussed medicines in diabetes and obesity treatment, particularly because of its effects on blood sugar, appetite and body weight.
If you’re searching for semaglutide brand names, the three major names to know are Wegovy, Ozempic and Rybelsus.
Semaglutide Brand Names
Although all three contain semaglutide, they are not interchangeable products. Their approved uses, doses and formulations can differ depending on the product and country.
1. Wegovy
Wegovy contains semaglutide and is primarily associated with chronic weight management. It works by activating GLP-1 receptors, which can help reduce appetite, increase feelings of fullness and influence food intake.
In 2026, oral obesity medicines have become an increasingly important part of the GLP-1 market, creating competition between traditional injectable treatments and newer tablet formulations.
2. Ozempic
Ozempic is a once-weekly injectable semaglutide medicine primarily used for adults with type 2 diabetes.
It helps improve blood-glucose control by enhancing glucose-dependent insulin secretion and reducing inappropriate glucagon secretion. It can also reduce appetite and body weight.
A common mistake is to treat Ozempic and Wegovy as simply two names for the same weight-loss drug. They contain the same active ingredient, but their approved indications and dosing schedules are different.
3. Rybelsus
Rybelsus is the oral tablet form of semaglutide used for type 2 diabetes.
Its tablet formulation is particularly important because it demonstrates that GLP-1-based treatment does not necessarily have to be delivered through an injection. However, oral semaglutide has specific administration requirements, so patients should follow the product instructions carefully.
How Does Semaglutide Work?
Semaglutide mimics the action of the naturally occurring hormone GLP-1 (glucagon-like peptide-1).
Its effects include:
- Increasing glucose-dependent insulin secretion
- Reducing glucagon secretion
- Slowing gastric emptying to varying degrees
- Increasing feelings of fullness
- Reducing appetite and food intake
These effects explain why semaglutide has become important in both diabetes management and obesity treatment.
Semaglutide vs Other GLP-1 Drugs
Semaglutide is only one member of the broader GLP-1 drug category. Other medicines include liraglutide, dulaglutide, exenatide and lixisenatide, while newer drugs such as tirzepatide target additional hormonal pathways.
Bottom Line
The main semaglutide brand names to remember are Wegovy, Ozempic and Rybelsus. They share the same active ingredient but differ in formulation, approved uses and dosing.
Disclaimer: This article is for educational purposes only and is not medical advice. Prescription medicines should be used only under the guidance of an appropriately qualified healthcare professional. Do not start, stop or switch semaglutide products without medical advice.
